. 2010 Aug 26;116(23):5010–5020. doi: 10.1182/blood-2010-06-290643

Table 3.

The effects of ATL146e and anti-CD1d on pulmonary leukocyte numbers are not additive

Cells (10⁵)	(a) NY1DD (n = 17)	(b) NY1DD ATL146e (n = 8)	(c) NY1DD anti-CD1d (n = 10)	(d) NY1DD ATL146e anti-CD1d (n = 4)
iNKT	0.43 (0.03)	0.30 (0.03)^*	0.20 (0.05)^*	0.16 (0.05)^**
NK	4.45 (0.77)	1.21 (0.30)^*	1.51 (0.22)^*	0.90 (0.08)^**
CD4	3.12 (0.37)	1.00 (0.20)^*	1.04 (0.21)^*	1.20 (0.30)^**
CD8	2.33 (0.32)	1.00 (0.15)^*	0.66 (0.18)^*	0.73 (0.23)^**
PMNs	2.14 (0.31)	0.38 (0.09)^*	0.84 (0.12)^*	0.52 (0.13)^**

NY1DD mice were treated with either ATL146e (10 ng/kg/minute, 3 days), anti-CD1d (10 μg/g/day, 2 days), or a combination of both. All treatments resulted in significantly decreased pulmonary leukocytes. Data represents the mean ± SEM. Data were analyzed by 1-way ANOVA with Neuman-Keuls posttesting.

P < .05 vs a.

^**

P < .05 vs a, not significantly different from b or c.